基于铁死亡相关基因构建肝细胞癌的预后模型

doi:10.3969/j.issn.1009-976X.2021.04.009

摘要/Abstract

摘要： 目的肝细胞癌是最常见的恶性肿瘤之一,具有预后差、复发率高的特点。铁死亡是最近发现的一种铁依赖性的细胞程序性死亡的形式,不同于细胞坏死、细胞凋亡、细胞自噬,由脂质过氧化驱动。该研究探讨了铁死亡相关基因与肝细胞癌患者预后之间的关系。方法从公共数据库中下载肝细胞癌患者的基因表达及相应的临床病理数据。使用单因素COX回归分析筛选预后相关的铁死亡相关基因,利用LASSO COX回归分析构建预后模型。多因素COX回归分析用于确认预后模型为独立的风险因素。最后,使用基因本体（GO）、京都基因组基因百科全书（KEGG）和单样本基因富集分析（ssGSEA）来进行功能性分析。结果通过单因素COX回归分析,确认了16个与预后显著相关的铁死亡相关基因（P < 0.0001）。利用LASSO COX回归分析,我们最终构建了一个基于10个铁死亡相关基因的预后模型。将队列中所有患者根据模型计算分为高风险组和低风险组,高风险组的肝细胞癌患者生存率较低,生存时间较短（P < 0.05）。多因素COX回归分析显示,风险评分是肝细胞癌患者的独立预后因素（P < 0.001）。此外,功能性分析显示,高风险组与低风险组之间的免疫微环境存在显著差异。结论本研究构建了基于10个铁死亡相关基因的预后模型,并且验证了该模型为肝细胞癌患者的独立预后因素,这为肝细胞癌患者的预后提供了参考。

关键词: 肝细胞癌, 铁死亡, 预后

Abstract: Objective Hepatocellular carcinoma （HCC） is one of the most common malignant tumors with poor prognosis and high recurrence rate. Ferroptosis is a recently discovered form of iron-dependent programmed cell death, which is different from cell necrosis, apoptosis, and autophagy and is driven by lipid peroxidation. This study explored the relationship between ferroptosis-related genes with prognosis in HCC patients. Methods Gene expression and corresponding clinicopathological data of HCC patients were downloaded from public databases. Univariate COX regression analysis was used to screen out prognostic ferroptosis-related genes, and Lasso COX regression analysis was used to construct a prognostic model. Multivariate COX regression analysis was used to confirm that the prognostic model was an independent risk factor. Finally, functional analyses were performed using Genome Ontology （GO）, Kyoto Genome Encyclopedia （KEGG）, and Single Sample Gene Enrichment Analysis （ssGSEA）. Results Univariate Cox regression analysis showed that 16 ferroptosis-related genes were significantly associated with prognosis （P<0.0001）. Using Lasso Cox regression analysis, we eventually constructed a prognostic model based on 10 ferroptosis-related genes. All patients in the cohort were divided into high-risk group and low-risk group according to the median of riskScore （Calculated by prognostic model）. The survival rate of patients with HCC in the high-risk group was lower and the survival time was shorter （P<0.05）. Multivariate Cox regression analysis showed that riskScore was an independent prognostic factor for patients with HCC （P<0.001）. In addition, functional analyses revealed significant differences in the immune microenvironment between the high-risk and low-risk groups. Conclusion In this study, a prognostic model based on 10 ferroptosis death-related genes was established and verified as an independent prognostic factor in patients with HCC, which provides a reference for the prognosis of patients with HCC.

Key words: hepatocellular carcinoma, ferroptosis, prognosis

中图分类号:

R735.7

王道笃, 赵其炯, 周志标, 何永越. 基于铁死亡相关基因构建肝细胞癌的预后模型[J]. 岭南现代临床外科, 2021, 21(04): 419-424.

WANG Dao-du, ZHAO Qi-jiong, ZHOU Zhi-biao, HE Yong-yue. Development of the prognosis signature for hepatocellular carcinoma based on ferroptosis-related genes[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 419-424.

参考文献

[1] Mcglynn KA, Petrick JL, El-Serag HB.Epidemiology of Hepatocellular Carcinoma[J]. Hepatology, 2021, 73(Suppl 1): 4-13.
[2] Hoshida Y, Nijman SM, Kobayashi M, et al.Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma[J]. Cancer Res, 2009, 69(18): 7385-7392.
[3] Nault JC, Villanueva A.Intratumor molecular and phenotypic diversity in hepatocellular carcinoma[J]. Clin Cancer Res, 2015, 21(8): 1786-1788.
[4] Torrecilla S, Sia D, Harrington AN, et al.Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma[J]. J Hepatol, 2017, 67(6): 1222-1231.
[5] Dixon SJ, Lemberg KM, Lamprecht MR, et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-72.
[6] Stockwell BR, Friedmann Angeli JP, Bayir H, et al.Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease[J]. Cell, 2017, 171(2): 273-285.
[7] Hassannia B, Vandenabeele P, Vanden Berghe T.Targeting Ferroptosis to Iron Out Cancer[J]. Cancer Cell, 2019, 35(6): 830-849.
[8] Liang C, Zhang X, Yang M, Dong X.Recent Progress in Ferroptosis Inducers for Cancer Therapy[J]. Adv Mater, 2019, 31(51): e1904197.
[9] Ritchie ME, Phipson B, Wu D, et al.limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): e47.
[10] Rhee SG, Kil IS.Multiple Functions and Regulation of Mammalian Peroxiredoxins[J]. Annu Rev Biochem, 2017, 86: 749-775.
[11] Rhee SG, WooHA, KangD. The Role of Peroxiredoxins in the Transduction of H₂O₂ Signals[J]. Antioxid Redox Signal, 2018, 28(7): 537-557.
[12] Kanai Y, Clemencon B, Simonin A, et al.The SLC1 high-affinity glutamate and neutral amino acid transporter family[J]. Mol Aspects Med, 2013, 34(2-3): 108-120.
[13] Gao M, Monian P, Quadri N, et al.Glutaminolysis and Transferrin Regulate Ferroptosis[J]. Mol Cell, 2015, 59(2): 298-308.
[14] Jiang L, Kon N, LiT, et al. Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015, 520(7545): 57-62.
[15] Chiu DK, Tse AP, Xu IM, et al.Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma[J]. Nat Commun, 2017, 8(1): 517.
[16] Kataoka S, Konishi Y, Nishio Y, et al.Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma[J]. DNA Cell Biol, 2004, 23(9): 549-560.
[17] Langhans B, Nischalke HD, Kramer B, et al.Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma[J]. Cancer Immunol Immunother, 2019, 68(12): 2055-2066.